Moderna (NasdaqGS:MRNA) plans to present Phase 1/2 data for its mRNA-4359 cancer antigen therapy combined with pembrolizumab ...
A team from the Max-Planck-Institut für Kohlenforschung, Hokkaido University, and Osaka University has discovered that subtle differences in molecular structure can have a major impact on the ...
A trio of common amino acids may hold the key to unlocking far more powerful gene therapies. Researchers found that adding ...
Scientists have discovered the internal shape of tiny drug-delivery particles - called lipid nanoparticles - has a big impact on how well our cells absorb them, paving the way to more efficient ...
Researchers at Harvard Medical School and Brigham and Women's Hospital designed an ingestible capsule that delivers liquid mRNA to the intestines, producing gene expression and reducing inflammation ...
Galit Meshulam-Simon is the associate director of Commercial Applications at Elegen. COVID-19 brought messenger RNA (mRNA) into the global spotlight, demonstrating its speed, flexibility, and efficacy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results